Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Authors
Keywords
-
Journal
LANCET
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-02-01
DOI
10.1016/s0140-6736(22)00016-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Device Therapy in Chronic Heart Failure
- (2021) Marat Fudim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
- (2021) Michael E. Nassif et al. NATURE MEDICINE
- Research Priorities for Heart Failure With Preserved Ejection Fraction
- (2020) Sanjiv J. Shah et al. CIRCULATION
- Deceases in Acute Heart Failure Hospitalizations during COVID‐19
- (2020) Zachary L Cox et al. EUROPEAN JOURNAL OF HEART FAILURE
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2020) Stefan D Anker et al. EUROPEAN HEART JOURNAL
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcatheter InterAtrial shunt device for the treatment of heart failure: Rationale and Design of the Pivotal Randomized Trial to REDUCE elevated left atrial pressure in patients with heart failure II (REDUCE LAP-HF II)
- (2019) Natalia Berry et al. AMERICAN HEART JOURNAL
- One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial
- (2018) Sanjiv J. Shah et al. JAMA Cardiology
- Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
- (2018) Masaru Obokata et al. EUROPEAN HEART JOURNAL
- Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction
- (2017) Sanjiv J. Shah Journal of Cardiovascular Translational Research
- Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview
- (2017) Sanjiv J. Shah Journal of Cardiovascular Translational Research
- Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
- (2017) Yashashwi Pokharel et al. JAMA Cardiology
- Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure])
- (2017) Ted Feldman et al. CIRCULATION
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
- (2016) Sanjiv J. Shah et al. CIRCULATION
- Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure
- (2016) Ted Feldman et al. Circulation-Heart Failure
- One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2016) David M. Kaye et al. Circulation-Heart Failure
- Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction
- (2016) Barry A. Borlaug et al. EUROPEAN HEART JOURNAL
- Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study
- (2016) Maria Del Trigo et al. LANCET
- A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial
- (2016) Gerd Hasenfuß et al. LANCET
- Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial
- (2015) Gerd Hasenfuss et al. JOURNAL OF CARDIAC FAILURE
- Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction
- (2013) Michael A. Burke et al. Circulation-Heart Failure
- Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
- (2012) Stuart J. Pocock et al. EUROPEAN HEART JOURNAL
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
- (2011) S. J. Pocock et al. EUROPEAN HEART JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started